Back to search

Article

SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine-Resistance in Pancreatic Cancer

2023-09-13

Abstract excerpt

Pancreatic cancer has a poor prognosis with its five-year survival rate lower than that of any other cancer type because it is difficult to detect in the early stages. Gemcitabine, a standard treatment for pancreatic cancer, often has poor outcomes for patients as a result of chemoresistance. Therefore, novel therapeutic targets must be identified to overcome gemcitabine-resistance. Here, we found that SLC38A5, a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df3daa1b-10d0-5d6b-8174-9280c7a12fa4
DOI
10.20944/preprints202309.0814.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine-Resistance in Pancreatic CancerDOI 10.20944/preprints202309.0814.v1
Select a neighboring publication to make it the new centre.